Retraction Note to : LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
| Errataetall: |
RetractionOf: Mol Cancer. 2020 May 8;19(1):85. - PMID 32384893 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Molecular cancer - 21(2022), 1 vom: 17. Juni, Seite 131 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liang, Yiran [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 21.06.2022 Date Revised 28.06.2023 published: Electronic RetractionOf: Mol Cancer. 2020 May 8;19(1):85. - PMID 32384893 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s12943-022-01576-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342370812 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342370812 | ||
| 003 | DE-627 | ||
| 005 | 20231226013946.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12943-022-01576-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1141.xml |
| 035 | |a (DE-627)NLM342370812 | ||
| 035 | |a (NLM)35715798 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liang, Yiran |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retraction Note to |b LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.06.2022 | ||
| 500 | |a Date Revised 28.06.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a RetractionOf: Mol Cancer. 2020 May 8;19(1):85. - PMID 32384893 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Retraction of Publication | |
| 700 | 1 | |a Song, Xiaojin |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yaming |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Bing |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Wenjing |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Lijuan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Hanwen |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Dianwen |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ning |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Tingting |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yajie |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Fangzhou |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Xiaoyan |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Qifeng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular cancer |d 2002 |g 21(2022), 1 vom: 17. Juni, Seite 131 |w (DE-627)NLM120915979 |x 1476-4598 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2022 |g number:1 |g day:17 |g month:06 |g pages:131 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12943-022-01576-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2022 |e 1 |b 17 |c 06 |h 131 | ||